Association between mitochondrial haplogroups and ranibizumab response in neovascular age-related macular degeneration

被引：0
|
作者：
Ascaso, Francisco [1 ,2 ]
Esteban, Olivia [1 ,2 ]
Montoya, Julio [2 ,3 ]
Montes, Paula [1 ]
Mateo, Javier [1 ,2 ]
Lara, Javier [1 ]
Ruiz-Pesini, Eduardo [2 ,3 ]
机构：
[1] Hosp Clin Univ Lozano Blesa, Dept Ophthalmol, Zaragoza, Spain
[2] Inst Aragones Ciencias Salud, Zaragoza, Spain
[3] Univ Zaragoza, Dept Bioquim Biol Mol & Celular, Zaragoza, Spain
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2019年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2954
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration
    Hurley S.F.
    Matthews J.P.
    Guymer R.H.
    Cost Effectiveness and Resource Allocation, 6 (1)
  • [32] Pegaptanib and ranibizumab for neovascular age-related macular degeneration: a systematic review
    Takeda, A. L.
    Colquitt, J.
    Clegg, A. J.
    Jones, J.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2007, 91 (09) : 1177 - 1182
  • [33] Assessment of the effectiveness and safety of ranibizumab in neovascular age-related macular degeneration
    Real Campana, Jose Manuel
    Carrera Lafuentes, Patricia
    Torron Fernandez-Blanco, Clemencia
    Huarte Lacunza, Rafael
    Varela Martinez, Isabel
    Rabanaque Hernandez, M. Jose
    MEDICINA CLINICA, 2011, 136 (11): : 471 - 477
  • [34] Pharmacogenetic Studies of Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration
    Den Hollander, A. I.
    Smailhodzic, D.
    Khan, H. A.
    Omar, A.
    Zhang, A. Y.
    Kirchhof, B.
    Chen, J.
    Hoyng, C. B.
    Koenekoop, R. K.
    Fauser, S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [35] Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
    Chakravarthy, Usha
    Harding, Simon P.
    Rogers, Chris A.
    Downes, Susan M.
    Lotery, Andrew J.
    Wordsworth, Sarah
    Reeves, Barnaby C.
    OPHTHALMOLOGY, 2012, 119 (07)
  • [36] Ranibizumab port delivery system in neovascular age-related macular degeneration
    Chandrasekaran, Priya R.
    Madanagopalan, V. G.
    THERAPEUTIC ADVANCES IN OPHTHALMOLOGY, 2022, 14
  • [37] Microperimetric changes in neovascular age-related macular degeneration treated with ranibizumab
    Alexander, P.
    Mushtaq, F.
    Osmond, C.
    Amoaku, W.
    EYE, 2012, 26 (05) : 678 - 683
  • [38] Ranibizumab for retinal angiomatous proliferation in neovascular age-related macular degeneration
    Lai, Timothy Y. Y.
    Chan, Wai-Man
    Liu, David T.
    Lam, Dennis S.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2007, 245 (12) : 1877 - 1880
  • [39] Microperimetric changes in neovascular age-related macular degeneration treated with ranibizumab
    P Alexander
    F Mushtaq
    C Osmond
    W Amoaku
    Eye, 2012, 26 : 678 - 683
  • [40] Ranibizumab therapy for predominantly hemorrhagic neovascular age-related macular degeneration
    Dikmetas, Ozlem
    Kadayifcila, Sibel
    Eldem, Bora
    Feyzullayeva, Ulkar
    NORTHERN CLINICS OF ISTANBUL, 2022, 9 (02) : 173 - 179
12345